United-Guardian Soars in Q1 on Dual-Engine Growth

HAUPPAUGE, NY – May 08, 2026 – United-Guardian, Inc. (NASDAQ:UG) delivered a robust first-quarter performance, announcing a significant surge in sales and profitability that signals a strong rebound and strategic momentum for the specialized manufacturer. The company reported first-quarter net sales of $2.87 million, a 15.8% increase from $2.48 million in the same period last year. Net income saw an even more dramatic rise, climbing 46% to $818,902, or $0.18 per share, up from $560,895, or $0.12 per share, in the first quarter of 2025.

The impressive results were driven by a powerful combination of resurgent demand in its core pharmaceutical and cosmetic ingredient segments, supplemented by a one-time settlement payment.

“I am happy to report that sales and earnings increased in the first quarter of 2026 compared with the first quarter of 2025,” stated Donna Vigilante, President of United-Guardian. “Our financial performance was primarily driven by increased sales of both our pharmaceuticals and cosmetic ingredients.”

Pharmaceutical Sales Fueled by Renacidin and Recovery

A key driver of the quarter's success was the company's pharmaceutical division, which posted a 24% increase in sales. This growth was largely attributed to heightened demand for Renacidin®, United-Guardian's flagship pharmaceutical product. Renacidin is a specialized irrigation solution used to dissolve certain types of bladder calculi and prevent mineral encrustations in catheters, a critical need in urological care.

The product operates within the continuous bladder irrigation market, a sector valued at over $1.4 billion and projected to grow at a steady compound annual growth rate of approximately 5%. This growth is underpinned by demographic trends, including an aging population and a rising incidence of urological disorders, providing a favorable backdrop for Renacidin's market expansion. The company has indicated an ongoing project to increase outreach and market penetration for the product, aiming to capitalize on this expanding market.

Further bolstering the quarter’s income was a one-time settlement of $303,133. This payment stemmed from an unexpected shutdown at the facility of a contract manufacturer for Renacidin in late 2023, which had previously resulted in lost sales. While the settlement provided a significant, non-recurring boost to the bottom line, it also represents the resolution of a major supply chain disruption, allowing the company to move forward with a more stable production outlook.

Cosmetic Ingredients Bounce Back as Distributor Restocks

The company's cosmetic ingredients segment also demonstrated remarkable strength, with sales climbing 21% year-over-year. The primary catalyst for this turnaround was the normalization of purchasing patterns from its largest cosmetic ingredient distributor, Ashland Specialty Ingredients (ASI).

According to the company, purchases by ASI surged by an impressive 45% in the first quarter of 2026 compared to the same period in 2025. This follows a period of suppressed orders in 2025, which Ms. Vigilante attributed to ASI carrying excess inventory. “This excess inventory has now been worked off, and they have resumed regular purchase levels,” she noted, signaling the restoration of a critical sales channel.

The renewed strength in the ASI relationship is particularly noteworthy. It appears to be unaffected by Ashland's recent strategic partnership with IMCD US, which became its exclusive distributor for certain personal and home care ingredients in the United States as of April 1, 2026. The continued robust purchasing by ASI suggests that its distribution agreement for United-Guardian's specialized products, which include the Lubrajel® line of hydrogels and orchid extracts, operates independently.

A Forward-Looking Strategy Built on Natural Trends and Market Expansion

Beyond the impressive quarterly figures, United-Guardian is executing a multi-pronged strategy aimed at sustaining its growth trajectory. A central pillar of this plan is an increased emphasis on expanding its line of "natural" cosmetic ingredients. The company offers a portfolio of natural hydrogels like Lubrajel Natural and Lubrajel Marine, which are designed to meet soaring consumer demand for clean and sustainable beauty products.

This strategic focus is well-timed. The global market for natural cosmetic ingredients, valued at over $11.6 billion, is projected to expand at an aggressive 8.6% CAGR through 2034. As consumers increasingly scrutinize labels and prioritize plant-based, eco-friendly formulations, United-Guardian's investment in this category positions it to capture a significant share of this high-growth market.

Complementing its product innovation is a concerted effort to broaden its market reach. The company highlighted that "new distribution agreements in place" are a key reason for its optimistic outlook for the remainder of 2026. While specific details of the newest partners were not disclosed, this follows a pattern of network expansion, including a previously announced agreement with Brenntag Specialties. These agreements are crucial for extending the global footprint of its diverse product portfolio, which also includes medical lubricants and sexual wellness ingredients.

A Picture of Financial Health

Underpinning this operational success is a remarkably strong financial position. For a micro-cap company with a market capitalization of around $31 million, United-Guardian exhibits financial metrics that suggest both stability and efficiency. The company boasts a trailing-twelve-month net profit margin of nearly 20%, outperforming the industry average.

Furthermore, its balance sheet is exceptionally healthy, characterized by a high liquidity ratio and virtually no debt. This financial fortitude provides the company with the flexibility to invest in research and development, pursue new market opportunities, and navigate potential economic headwinds without the constraints of heavy leverage. With its key distributor back on track, its flagship pharmaceutical product gaining momentum, and a clear strategy aligned with major market trends, United-Guardian has positioned itself for continued growth throughout 2026.